| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Biologics and postbiologics: novel immunotherapeutics for the induction and maintenance of remission
|
van Eden, Willem
|
|
2010
|
15 |
1-2 |
p. 71-77
7 p.
|
artikel
|
| 2 |
Computational toxicology—a tool for early safety evaluation
|
Merlot, Cédric
|
|
2010
|
15 |
1-2 |
p. 16-22
7 p.
|
artikel
|
| 3 |
Contents
|
|
|
2010
|
15 |
1-2 |
p. iii-
1 p.
|
artikel
|
| 4 |
Contents
|
|
|
2010
|
15 |
1-2 |
p. i-
1 p.
|
artikel
|
| 5 |
Cyclotides as templates in drug design
|
Henriques, Sónia Troeira
|
|
2010
|
15 |
1-2 |
p. 57-64
8 p.
|
artikel
|
| 6 |
Discovery of PDE10A inhibitor, PF-2545920
|
Walker, Michael A.
|
|
2010
|
15 |
1-2 |
p. 79-
1 p.
|
artikel
|
| 7 |
Epigenetic opportunities and challenges in cancer
|
Best, Jonathan D.
|
|
2010
|
15 |
1-2 |
p. 65-70
6 p.
|
artikel
|
| 8 |
Mitochondrial pharmacogenomics: barcode for antibiotic therapy
|
Pacheu-Grau, David
|
|
2010
|
15 |
1-2 |
p. 33-39
7 p.
|
artikel
|
| 9 |
Molecular fields in drug discovery: getting old or reaching maturity?
|
Cross, Simon
|
|
2010
|
15 |
1-2 |
p. 23-32
10 p.
|
artikel
|
| 10 |
Orally bioavailable proteasome inhibitors: preclinical development of PR-047
|
|
|
2010
|
15 |
1-2 |
p. 78-
1 p.
|
artikel
|
| 11 |
Synthetic therapeutic peptides: science and market
|
Vlieghe, Patrick
|
|
2010
|
15 |
1-2 |
p. 40-56
17 p.
|
artikel
|
| 12 |
The shrinking of the knowledge base – what is the impact of this on the speed and security of drug development?
|
Branthwaite, Paul
|
|
2010
|
15 |
1-2 |
p. 1-2
2 p.
|
artikel
|
| 13 |
Visualizing the drug target landscape
|
Campbell, Stephen J.
|
|
2010
|
15 |
1-2 |
p. 3-15
13 p.
|
artikel
|
Tijdschrift beschrijving